|
Market Closed -
TEL AVIV STOCK EXCHANGE
07:44:52 2026-10-30 EDT
|
5-day change | 1st Jan Change | ||
| 1,020.00 ILa | 0.00% |
|
-0.58% | -6.76% |
| Market Cap | 116M 0 37.43M 33.52M 30.93M 27.99M 52.34M 3.56B 53.18M 369M 147M 1.87B 140M 137M 5.91B | P/E 2024 |
24.5x | P/E 2025 | -6.91x |
|---|---|---|---|---|---|
| Enterprise Value | 244M 0 78.58M 70.38M 64.93M 58.76M 110M 7.48B 112M 775M 309M 3.92B 295M 289M 12.4B | EV / Sales 2024 |
0.87x | EV / Sales 2025 | 0.84x |
| Free-Float |
17.21% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 week | -0.58% | ||
| Current month | -8.85% | ||
| 1 month | -8.85% | ||
| 3 months | -7.94% | ||
| 6 months | -11.30% | ||
| Current year | -6.76% |
| 1 week | 1,012 |  | 1,050 |
| 1 month | 1,012 | | 1,209 |
| Current year | 1,006 | | 1,348 |
| 1 year | 1,006 | | 1,348 |
| 3 years | 1,006 | | 1,679 |
| 5 years | 1,006 | | 2,566 |
| 10 years | 1,006 | | 4,076 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 82 | 1993-08-23 | |
Yuval Bernshtein
DFI | Director of Finance/CFO | 46 | 2018-10-31 |
| President | 80 | 2010-06-27 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 82 | 2010-06-24 | |
| Director/Board Member | 80 | - | |
Avraham Bigger
CHM | Chairman | 80 | 2015-04-14 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -0.58% | -13.04% | -38.18% | 37.43M | |
| +6.63% | +5.13% | +68.86% | +145.20% | 1,224B | |
| +1.53% | +2.84% | +47.48% | +89.01% | 662B | |
| +1.68% | +1.96% | +29.16% | +109.31% | 514B | |
| +0.29% | +3.02% | +53.88% | +66.89% | 388B | |
| +3.83% | -0.62% | +69.01% | +42.32% | 361B | |
| +1.41% | +4.73% | +35.58% | +58.41% | 302B | |
| +5.42% | +7.13% | +9.50% | +34.45% | 271B | |
| +1.97% | +3.01% | +57.91% | +76.14% | 249B | |
| +4.03% | +5.36% | +39.76% | +116.14% | 205B | |
| Average | +1.79% | +2.20% | +39.81% | +69.97% | 417.69B | |
| Weighted average by Cap. | +1.78% | +3.04% | +50.86% | +96.69% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 322M 0 103M 92.63M 85.46M 77.34M 145M 9.85B 147M 1.02B 407M 5.15B 388M 380M 16.32B | 301M 0 96.76M 86.67M 79.96M 72.35M 135M 9.21B 137M 954M 381M 4.82B 363M 355M 15.27B |
| Net income | 6.21M 0 2M 1.79M 1.65M 1.49M 2.79M 190M 2.83M 19.67M 7.85M 99.43M 7.49M 7.33M 315M | -18.07M -0 -5.81M -5.2M -4.8M -4.34M -8.12M -553M -8.26M -57.28M -22.85M -290M -21.81M -21.34M -917M |
| Net Debt | 127M 0 40.86M 36.59M 33.76M 30.55M 57.13M 3.89B 58.05M 403M 161M 2.04B 153M 150M 6.45B | 128M 0 41.15M 36.86M 34.01M 30.77M 57.54M 3.92B 58.47M 406M 162M 2.05B 154M 151M 6.5B |
Employees
390
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-30 | ILA 1,020.00 | 0.00% | 10 |
| 26-10-29 | ILA 1,020.00 | 0.00% | 758 |
| 26-10-28 | ILA 1,020.00 | 0.00% | 10 |
| 26-10-26 | ILA 1,020.00 | -0.58% | 1,100 |
| 26-10-23 | ILA 1,026.00 | -0.77% | 2,831 |
- Stock Market
- Stocks
- REKA Stock
Select your edition
All financial news and data tailored to specific country editions
